Publications
- Multi-target-directed therapeutic potential of 7-methoxytacrine-adamantylamine heterodimers in the Alzheimer's disease treatment2017 | Publication without faculty affiliation
- SAR study to find optimal cholinesterase reactivator against organophosphorous nerve agents and pesticides2016 | Publication without faculty affiliation
- The antioxidant additive approach for Alzheimer's disease therapy: New ferulic (Lipoic) acid plus melatonin modified tacrines as Cholinesterases inhibitors, direct antioxidants, and nuclear factor (Erythroid-Derived 2)-like 2 activators2016 | Publication without faculty affiliation
- 7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer's Disease Treatment2015 | Publication without faculty affiliation
- Pharmacotherapy of Alzheimer's Disease: Current State and Future Perspectives2014 | Publication without faculty affiliation
- 7-Methoxytacrine-Adamantylamine Heterodimers as Cholinesterase Inhibitors in Alzheimer's Disease Treatment - Synthesis, Biological Evaluation and Molecular Modeling Studies2013 | Publication without faculty affiliation
- Phenoxytacrine derivatives: Low-toxicity neuroprotectants exerting affinity to ifenprodil-binding site and cholinesterase inhibition2024 | Faculty of Science, First Faculty of Medicine, Third Faculty of Medicine
- Nakagami imaging and morphing for multiple sclerosis lesion volume estimation2024 | Publication without faculty affiliation
- Differentiated SH-SY5Y neuroblastoma cells as a model for evaluation of nerve agent-associated neurotoxicity2023 | Faculty of Pharmacy in Hradec Králové, First Faculty of Medicine
- Structure-Guided Design of N-Methylpropargylamino- Quinazoline Derivatives as Multipotent Agents for the Treatment of Alzheimer's Disease2023 | Faculty of Pharmacy in Hradec Králové, Faculty of Science
Loading network view...